Tweet from the firm says SD Biosensor has just started production from its Manesar, Haryana facility with a capacity of 500,000 rapid test kits per week
NEW DELHI| After China’s rapid testing kits failed in India, South Korean firm stood to aid India with the rapid testing kits. A firm based in South Korea will be making rapid testing kits for the coronavirus in Haryana’s Manesar.
Union Health Ministry talking addressing the press on Tuesday ask not to use the Chinese rapid testing kits for two days due to continued complaints from more than three states across the nation. The Indian Embassy in South Korea tweeted about the venture.
The tweet read SD Biosensor (South Korea based company) has just started production from its Manesar, Haryana facility with a capacity of 500,000 rapid test kits per week. This will be further enhanced in the coming weeks to meet growing demand.
SD Biosensor (South Korea based company) has just started production from its Manesar, Haryana facility with a capacity of 500,000 rapid test kits per week. This will be further enhanced in the coming weeks to meet growing demand: Embassy of India, Seoul (South Korea) #COVID19 pic.twitter.com/tIfBlzC08u
— ANI (@ANI) April 21, 2020
The chief head of the Firm, Young-Shik Cho, discussed the matter with Indian Ambassador Sripriya Ranganathan. The Indian ambassador also visited the manufacturing facility of SD Biosensor.
Such a pleasure to visit the sparkling facilities of SD Biosensor. SDB’s Manesar unit has started producing rapid test kits to support #IndiaFightsCoronavirus. A fine example of profitable India-ROK collaboration that helps the world @MEAIndia @MOFAkr_eng https://t.co/IJAa8aGRhd
— Sripriya Ranganathan (@ambsripriya) April 21, 2020
“We are procuring 75,000 high-quality rapid testing kits at a benchmark price of ₹337 + GST from a South Korean company based in India, which has proven to be the lowest bidder. The rate we have been able to close at is the lowest in India,” the minister’s tweet read.
India has also signed a deal with South Korean firm M/s Humasis Ltd for the supply of 500,000 tests to the Indian Council of Medical Research, the embassy tweeted.
Aggressive testing was the way South Korea got the upper hand over the highly contagious virus, which has so far infected more than 18,000 people in India.
Worldwide, more than 24 lakh people have coronavirus, nearly 170,000 have died. US has reported the highest number of COVID-19 cases with 230,000 cases, more than 42,000 deaths have been reported from the country.
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.